Last updated: 2026-09-08 08:39:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
MIRA Pharmaceuticals, Inc. (MIRA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.77, with a market capitalisation of $32.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.60 to $2.45. This page covers its latest market performance, valuation, price trends and company information.
$32.10M | |
$0.78 | |
$7.98 | |
$0.51 | |
-- | |
357.00 | |
561.43K | |
-- | |
$2.45 | |
$0.60 | |
-- | |
-- |
MIRA Pharmaceuticals, Inc. (MIRA) is trading at $0.75 in pre-market trading as of 2026-09-08 08:26:00, -- from the previous close of $0.00
Pre-market trading shows how investors are pricing MIRA before the regular session opens. The current pre-market price is -- the previous close, indicating positive early trading sentiment.
Over the past seven days, MIRA Pharmaceuticals, Inc. (MIRA) moved from $0.77 to $0.77, representing a gain of 0.38% ($0.00).
The stock traded between $0.72 and $1.10 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 4.40 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 9.4%
MIRA is currently trading at $0.77, placing it 9.4% of the way from its 52-week low of $0.60 to its 52-week high of $2.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of MIRA Pharmaceuticals, Inc. (MIRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.